Driven by Expertise.
Guided by Vision.
Meet the founder whose 25-year pharmaceutical journey shapes every solution Siprichem delivers.
Add Dr. K.P. Jain's photo here
Recommended: 500×600px, professional portrait
Dr. Kirti Prakash Jain brings over two decades of transformative leadership across the pharmaceutical and API manufacturing sectors. His career spans the full spectrum of pharmaceutical innovation — from synthetic design and process chemistry to large-scale commercial manufacturing and regulatory compliance.
Throughout his career, Dr. Jain has held senior leadership positions — AVP, Senior GM, and Head of R&D — at some of India's most respected pharmaceutical companies, building high-performing teams and delivering robust solutions for global clients in both regulated and semi-regulated markets.
Sun Pharma
Senior leadership in API process development and manufacturing operations.
IPCA Laboratories
R&D leadership — process optimization and scale-up for generic APIs.
Hikal Ltd.
Advanced process chemistry and CDMO operations leadership.
Ami Lifesciences
Head of R&D — developed strategic cost reduction models and optimized synthesis routes.
Cadila Pharmaceuticals & Ranbaxy Ltd.
Early career foundation in organic chemistry, analytical development, and drug substance R&D.
Founded Siprichem Innolab LLP
Bringing 25 years of expertise to India's MSME pharma ecosystem as an innovation partner.
Dr. Jain's hands-on capabilities span the entire pharmaceutical value chain — making him uniquely positioned to consult, design, and deliver.
"At Siprichem Innolab LLP, we are not just service providers — we are your strategic innovation partners. By integrating process engineering, rigorous quality standards, and cutting-edge technologies like flow chemistry, my team and I are committed to solving your most complex manufacturing challenges."
DuPont Process Safety
Certified trainer in industrial chemical process safety standards.
Quality by Design (QbD)
Expertise in ICH Q8/Q9/Q10 framework for pharmaceutical development.
ICH Q7 / M7 Guidelines
Active pharmaceutical ingredients GMP and mutagenic impurity assessment.
